news
The Hindu
2026-08-18
U.S. FDA updates classification for Aurobindo's North Carolina facility
The FDA has classified Aurobindo’s North Carolina plant as 'Voluntary Action Indicated,' allowing pending applications for inhalers and other products to move forward.